NLS Pharmaceutics
NLSP
NLSP
9 hedge funds and large institutions have $7.11M invested in NLS Pharmaceutics in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
9
Holders Change
+2
Holders Change %
+28.57%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$0 |
| 2 |
JGC
2
J. Goldman & Co
New York
|
$225K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BI
1
BVF Inc
San Francisco,
California
| $6.32M | – | – | – |
|
|
AAA
2
Affinity Asset Advisors
New York
| $440K | +$61.5K | +1,398 | +16% |
|
|
JGC
3
J. Goldman & Co
New York
| $225K | -$484 | -11 | -0.2% |
|
4
Renaissance Technologies
New York
| $60K | +$24.8K | +565 | +70% |
|
|
TSS
5
Two Sigma Securities
New York
| $40.8K | +$40.8K | +927 | New |
|
6
Geode Capital Management
Boston,
Massachusetts
| $15.8K | – | – | – |
|
7
UBS Group
Zurich,
Switzerland
| $3.75K | +$3.75K | +85 | New |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $110 | +$110 | +3 | New |
|
9
Bank of America
Charlotte,
North Carolina
| $99 | – | – | – |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$35.4K | -586 | Closed |
|